MIPS MIPS Endotoxin Detection System

Overview

The MIPS Endotoxin Detection System is a portable, electrochemical impedance spectroscopy (EIS)-based analytical platform engineered for rapid, label-free quantification of endotoxin (lipopolysaccharide, LPS) in aqueous matrices. Unlike traditional Limulus Amebocyte Lysate (LAL)-based assays—which rely on enzymatic cascade reactions and require reagent preparation, incubation, and optical readout—the MIPS system employs a functionalized gold-coated quartz microfluidic sensor chip. This chip is pre-modified with LPS-specific molecular recognition elements (e.g., polymyxin B derivatives or synthetic peptide ligands), enabling direct, real-time binding-induced impedance shifts at the electrode–electrolyte interface. The system’s core architecture integrates a precision microfluidic module, embedded miniature peristaltic pumps, and a temperature-stabilized test chamber—ensuring consistent hydrodynamic conditions and minimizing nonspecific adsorption. Designed for field-deployable and point-of-use applications, it delivers quantitative results within 8–12 minutes per sample, without lyophilized reagents, cold-chain logistics, or operator-dependent endpoint interpretation.

Key Features

• Label-free, real-time detection via electrochemical impedance spectroscopy (EIS) with sub-EU/mL sensitivity (LOD: 0.00742 EU/mL)
• Integrated microfluidic test chamber with gold-quartz sensor chips pre-functionalized for selective LPS capture
• Portable form factor (weight: <1.2 kg) with onboard rechargeable Li-ion battery supporting ≥8 hours of continuous operation
• Multi-channel configurations available (1-, 2-, or 4-channel modules) for parallel sample screening in QC environments
• On-device calibration verification using NIST-traceable endotoxin standards (E. coli O113:H10 reference material)
• Ruggedized housing rated IP54 for use in clinical utility rooms, water treatment facilities, and field laboratories
• Automated fluidic priming, zero-point compensation, and drift correction algorithms embedded in firmware

Sample Compatibility & Compliance

The MIPS Endotoxin Detection System is validated for use with low-conductivity aqueous samples including hemodialysis water, dialysate concentrate, purified water (PW), water for injection (WFI), municipal drinking water, and raw surface water. It is not intended for undiluted biological fluids (e.g., whole blood, serum, or urine) without prior filtration and conductivity adjustment (sample conductivity must remain within 5–150 µS/cm). The system supports compliance-driven workflows aligned with pharmacopeial standards: USP (Bacterial Endotoxins Test), European Pharmacopoeia EP 2.6.14, and ISO 11737-1 (Microbiology of medical devices). While the instrument itself does not generate GLP/GMP audit trails by default, its companion software (MIPS EndoTrack™ v3.2) provides optional 21 CFR Part 11-compliant user access control, electronic signatures, and immutable audit logs when deployed on networked, domain-joined workstations.

Software & Data Management

MIPS EndoTrack™ v3.2 is a desktop application supporting Windows 10/11 and macOS 12+, offering full instrument control, calibration management, and report generation. Key capabilities include: automated standard curve fitting using four-parameter logistic (4PL) regression; batch processing of multi-channel runs with outlier flagging based on impedance phase angle deviation; export of raw impedance spectra (.csv), processed concentration data (.xlsx), and PDF-formatted compliance reports. All measurement metadata—including sensor ID, calibration date, operator ID, ambient temperature/humidity, and fluidic pressure logs—is embedded in each result file. Data encryption at rest (AES-256) and TLS 1.3-secured remote firmware updates ensure cybersecurity alignment with IEC 62443-3-3 requirements for laboratory instrumentation.

Applications

• Pharmaceutical water systems: Routine monitoring of PW, WFI, and clean steam condensate in GMP manufacturing suites
• Hemodialysis centers: On-site verification of dialysate purity per AAMI/ISO 13959 and CMS Condition of Participation standards
• Environmental surveillance: Quantitative assessment of endotoxin load in river, reservoir, and wastewater influent/effluent streams
• Biomedical R&D: High-throughput screening of endotoxin contamination in cell culture media, buffer solutions, and excipient batches
• Agricultural water safety: Field-based evaluation of irrigation water used in hydroponic and aquaponic production systems

FAQ

Does the MIPS system replace the LAL assay for regulatory submissions?
No—it is intended as a complementary rapid screening tool. Final release testing for pharmaceutical products must still follow pharmacopeial LAL methods unless formally validated and approved under a regulatory comparability protocol.
Can the sensor chips be reused?
Each gold-quartz sensor chip is single-use and factory-calibrated. Reuse compromises binding site integrity and introduces carryover risk; chips are auto-identified via RFID and invalidated after one run.
What maintenance is required between analyses?
Only a 30-second flush cycle with deionized water is performed automatically post-measurement; no chemical cleaning or chip regeneration is supported.
Is method validation support provided?
Yes—MIPS supplies IQ/OQ documentation templates, sensor chip lot-specific performance certificates, and application notes aligned with ASTM D8079-17 (Standard Guide for Endotoxin Testing in Water Systems).